Khan Sajid

Assistant Professor/Research

University of Texas Health Science Center at San Antonio

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Yuewan Luo

Københavns Universitet

DENMARK

View details

Xingui Liu

Assistant Professor

University of Florida

UNITED STATES

View details

Dongwen Lv

Assistant Professor

UT Health San Antonio

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Khan Sajid

Research Interests

Explore related searches

Contact this professor

Articles (9)

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers

Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216

Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells

PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity

Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity.

Collaborators (3)

Yuewan Luo

Xingui Liu

Dongwen Lv

Make your next move.